US2014142316A1PendingUtilityA1

Tricyclic Compounds, Compositions, And Methods

62
Assignee: PFIZERPriority: Feb 2, 2007Filed: Apr 16, 2013Published: May 22, 2014
Est. expiryFeb 2, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61P 37/02A61P 7/06A61P 7/10A61P 35/02A61P 37/08A61P 43/00A61P 3/04A61P 37/06A61P 9/00A61P 27/02A61P 25/00A61P 27/04A61P 25/14A61P 3/10A61P 25/28A61P 27/16A61P 29/00A61P 25/02A61P 25/16A61P 3/14A61P 27/14A61P 25/24A61P 25/18A61P 11/06A61P 1/00A61P 1/18A61P 17/14A61P 17/08A61P 11/16A61P 17/06A61P 19/02A61P 11/00A61P 17/00A61P 19/10A61P 19/00A61P 1/04A61P 19/06A61P 21/04A61P 13/12A61P 1/02C07D 213/72C07D 213/89A61K 31/44C07F 9/58C07D 213/75
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.

Claims

exact text as granted — not AI-modified
1 - 8 . (canceled) 
     
     
         9 . A compound as depicted by

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.